deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06268665

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Sponsor: University of California, Davis

Conditions Breast Cancer Breast Cancer Invasive Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage III Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIc Breast Cancer Stage IV Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Carcinoma Breast Neoplasm Cancer of Ovary Cancer, Breast Invasive Breast Cancer Malignant Breast Neoplasm Malignant Tumor of Breast Mammary Cancer Mammary Carcinoma Ovarian Cancer Ovarian Cancer Stage 1 Ovarian Cancer Stage 2 Ovarian Cancer Stage 3 Ovarian Cancer Stage IA Ovarian Cancer Stage IB Ovarian Cancer Stage IC Ovarian Cancer Stage II Ovarian Cancer Stage III Ovarian Cancer Stage IIIC Ovarian Cancer Stage IIIb Ovarian Cancer Stage IV Ovary Cancer Ovary Neoplasm Tumors, Breast
Interventions Tart Cherry Juice
Updated 4 times since 2024 Last updated: Mar 2, 2026 Started: Aug 15, 2024 Primary completion: Oct 31, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Breast Cancer and Breast Cancer Invasive and is currently actively recruiting participants. University of California, Davis leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2026 · 18 months · monthly snapshotRecruiting~Mar 2026 – present · 5 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting PHASE2

  2. Sep 2024 — Mar 2026 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE2

  4. Mar 2024 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, Davis
Data source: University of California, Davis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations